Skip to main content
HR 7217 115th Congress House

IMPROVE Act

Official title: To amend title XIX of the Social Security Act to provide States with the option of providing coordinated care for children with complex medical conditions thro… Show full official titleShow less

Official title: To amend title XIX of the Social Security Act to provide States with the option of providing coordinated care for children with complex medical conditions through a health home, and for other purposes.

Introduced: December 6, 2018 See on congress.gov
Health Birth defectsBlood and blood diseasesBusiness recordsCardiovascular and respiratory health
More subjectsShow fewer subjects
Child healthCivil actions and liabilityDisability and paralysisEmergency medical services and trauma careFamily servicesHIV/AIDSHealth care costs and insuranceHealth care coverage and accessHealth care qualityHealth personnelHealth programs administration and fundingHealth promotion and preventive careHealth technology, devices, suppliesHereditary and development disordersHome and outpatient care
This bill died when the 115th Congress ended
It never became law before the 115th Congress (2017–2018) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 10 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Dec 12, 2018
Received in the Senate.
Dec 11, 2018
On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 400 - 11 (Roll no. 428). (text: CR H10043-10047)
Dec 11, 2018
At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
Dec 11, 2018
Considered as unfinished business. (consideration: CR H10083)
Dec 11, 2018
DEBATE - The House proceeded with forty minutes of debate on H.R. 7217.
Dec 11, 2018
Considered under suspension of the rules. (consideration: CR H10043-10052)
Dec 11, 2018
Mr. Barton moved to suspend the rules and pass the bill.
Dec 11, 2018
Motion to reconsider laid on the table Agreed to without objection.
Dec 6, 2018
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Dec 6, 2018
Introduced in House
 Votes taken on this bill 1
DateChamberWhat was voted onResultYes–No
Dec 11, 2018 House · vote #428 On Motion to Suspend the Rules and Pass Passed 400–11 See who voted →
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action December 12, 2018

Received in the Senate.

 Plain-English summary Congressional Research Service

Improving Medicaid Programs and Opportunities for Eligible Beneficiaries Act or the IMPROVE Act

This bill establishes a state Medicaid option to provide for medical assistance with respect to coordinated care provided through a health home (i.e., a designated provider or team of health-care professionals) for children with medically complex conditions. States must determine payment methodologies in accordance with specified requirements; payments also temporarily qualify for an enhanced federal matching rate.

The bill also makes a series of reductions relating to federal Medicaid expenditures. Among other changes, the bill reduces the federal matching rate for states that do not have required asset-verification programs for determining Medicaid eligibility.

Further, drug manufacturers with Medicaid rebate agreements for covered outpatient drugs must disclose drug product information. Manufacturers are subject to civil penalties for knowingly misclassifying drugs. Manufacturers are also required to compensate for rebates that were initially underpaid as a result of misclassification (whether or not such misclassification was committed knowingly).

Finally, the bill excludes specified wheelchairs and associated accessories from Medicare's competitive acquisition program (in which rates are set through a competitive bidding program rather than by an established fee schedule).

 Related & companion bills 2
 Bill text 3 versions

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 7217: IMPROVE Act. 115th Congress. Open America. https://openamerica.io/bill/115-HR-7217/
MLA
"H.R. 7217: IMPROVE Act." 115th Congress, 2026, Open America, https://openamerica.io/bill/115-HR-7217/.
Bluebook (legal)
H.R. 7217, 115th Cong. (2026), https://openamerica.io/bill/115-HR-7217/.
Markdown link
[H.R. 7217: IMPROVE Act](https://openamerica.io/bill/115-HR-7217/)
Report a problem